Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, February 01, 2017
The Pharmaceutical Research and Manufacturers of America (PhRMA) board of directors has elected new officers and welcomed a new member company.
read more
Monday, February 04, 2019
The Pharmaceutical Research and Manufacturers of America (PhRMA) elected three new officers to its board of directors.
read more
The Pharmaceutical Research and Manufacturers of America (PhRMA) appointed new leadership to its board of directors.
read more
Wednesday, December 09, 2015
America’s biopharmaceutical companies are currently developing 190 medicines to treat heart disease and stroke, according to a new report released from the Pharmaceutical Research and Manufacturers of America (PhRMA) and the Association of Black ...
read more
Wednesday, September 09, 2020
PhoreMost and XtalPi have entered into a drug discovery collaboration agreement. Financial details are not disclosed.
read more
Tuesday, November 10, 2020
PhoreMost and Oxford Biomedica have entered into a discovery collaboration to develop next-generation CAR-T cell therapies.
read more
Tuesday, November 17, 2020
PhoreMost and Oxford Biomedica have entered into a discovery collaboration to develop next-generation CAR-T cell therapies.
read more
Wednesday, January 08, 2020
PhoreMost has entered into a multi-project drug discovery collaboration with Boehringer Ingelheim.
read more
PhoreMost Ltd., has triggered a milestone payment in its multi-project target discovery collaboration with Boehringer Ingelheim. This was achieved by identifying and validating novel targets supporting Boehringer Ingelheim’s ambition to develop first...
read more
Wednesday, January 19, 2022
PhoreMost Ltd., has relocated its headquarters to Unity Campus, a high-specification technology and innovation park, owned by leading regional property developers and investors, Howard Group, in south Cambridge.
read more
Wednesday, January 22, 2020
PhoreMost has entered into a multi-project collaboration with Otsuka Pharmaceutical. Financial details of the agreement are not disclosed.
read more
Thursday, September 08, 2022
PhoreMost Ltd. has entered into a multi-project target discovery collaboration with Roche. Under the terms of the agreement, PhoreMost will receive an upfront payment and is eligible for preclinical success-based milestones. Further financial terms ...
read more
Phoenix Molecular Designs (PhoenixMD) has announced the completion of clinical trial supply manufacture for PMD-026.
read more
Phlow Corp. announced a significant expansion in its analytical capabilities, use of artificial intelligence (AI), workforce, and domestic infrastructure.
read more
Phlow Corp. and Antheia announced an ongoing partnership to onshore production of essential medicines and establish more efficient, agile, and resilient pharmaceutical supply chains in the United States.
read more